Comparison of Ventro-Cephalic to Dorso-Caudal Translatoric Glides in Management of Cervicogenic Headache

NCT ID: NCT07006454

Last Updated: 2025-06-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-18

Study Completion Date

2025-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a randomised control trial and the purpose of this study is to compare ventro-cephalic to dorso-caudal translatoric glides in management of cervicogenic headache.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be recruited into their respective groups using a coin toss method.Cervicogenic headache will be assesed using International Classification of Headache Disorders, 3rd edition:

A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.

C- Evidence of cause of headache demonstrated by at least 2 of these:

1. headache has developed in temporal relation to the onset of the cervical disorder or lesion.
2. headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder.
3. cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers.
4. headache is abolished following anaesthetic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis.

CEH subject selection is based on clinical criteria, however anaesthetic blockades is not used as a criterion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervicogenic Headache

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Control Trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Participants of group A will receive ventro-cephalic translatoric glide, total of 3 sets with 15 repetitions per set.

Duration (5 treatment sessions per week for 2 weeks)

Group Type EXPERIMENTAL

Ventro-Cephalic Translatoric Glide

Intervention Type PROCEDURE

Participants of group A will receive ventro-cephalic translatoric glides, total of 3 sets with 15 repetitions per set.

PROCEDURE:

1. Patient sits on low chair with back straight and therapist stand facing the patient's right side.
2. Therapist's stable hand: with the thumb and index finger of left hand fixate caudal vertebra.
3. Therapist's moving hand: therapist will place his/her right hand on left side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
4. Apply glide in ventro-cranial direction in the right angle of the treatment plane of the facet joint.

Group B

Participants of group B will receive Dorso-caudal translatoric glide, total of 3 sets with 15 repetitions per set.

Duration (5 treatment sessions per week for 2 weeks)

Group Type EXPERIMENTAL

Dorso-Caudal Translatoric Glide

Intervention Type PROCEDURE

Participants of group B will receive Dorso-caudal translatoric glides, total of 3 sets with 15 repetitions per set.

PROCEDURE:

1. Patient sits on low chair with back straight and therapist stand facing the patient's left side.
2. Therapist's stable hand: with the thumb and index finger of right hand fixate caudal vertebra.
3. Therapist's moving hand: therapist will place his/her left hand on right side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
4. Apply glide in dorso-caudal direction in the right angle of the treatment plane of the facet joint.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ventro-Cephalic Translatoric Glide

Participants of group A will receive ventro-cephalic translatoric glides, total of 3 sets with 15 repetitions per set.

PROCEDURE:

1. Patient sits on low chair with back straight and therapist stand facing the patient's right side.
2. Therapist's stable hand: with the thumb and index finger of left hand fixate caudal vertebra.
3. Therapist's moving hand: therapist will place his/her right hand on left side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
4. Apply glide in ventro-cranial direction in the right angle of the treatment plane of the facet joint.

Intervention Type PROCEDURE

Dorso-Caudal Translatoric Glide

Participants of group B will receive Dorso-caudal translatoric glides, total of 3 sets with 15 repetitions per set.

PROCEDURE:

1. Patient sits on low chair with back straight and therapist stand facing the patient's left side.
2. Therapist's stable hand: with the thumb and index finger of right hand fixate caudal vertebra.
3. Therapist's moving hand: therapist will place his/her left hand on right side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
4. Apply glide in dorso-caudal direction in the right angle of the treatment plane of the facet joint.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Age 18 to 44 years old

* Both male and female A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.

C- Evidence of cause of headache demonstrated by at least 2 of these:

1. headache has developed in temporal relation to the onset of the cervical disorder or lesion.
2. headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder.
3. cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers.
4. headache is abolished following diagnostic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis

Exclusion Criteria

* 1- Tension-type headaches and migraine 2- History of Vertigo or Dizziness 3- Already taking manual therapy treatment 4- Prior surgery to the head and neck 5- Trauma
Minimum Eligible Age

18 Years

Maximum Eligible Age

44 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foundation University Islamabad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Foundation University College of Physical Therapy

Islamabad, , Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aeysha Bibi, DPT

Role: CONTACT

+923058766593

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hafiz Ali Bin Asim, MS-SPT

Role: primary

+923135088144

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FUI/CTR/2024/79

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.